This inventor holds 1 USPTO granted patent. Top assignee: The University of Queensland. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Christopher John Armishaw: Innovator in Cyclised Conotoxin Peptides
Introduction
Christopher John Armishaw is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative work on cyclised conotoxin peptides. His research focuses on the preparation and application of these peptides, which hold promise for various medical uses.
Latest Patents
Armishaw holds 1 patent related to his work. The patent, titled "Cyclised Conotoxin Peptides," details the processes for preparing these peptides and their potential pharmaceutical applications. This invention represents a significant advancement in the development of new therapeutic agents.
Career Highlights
Christopher John Armishaw is affiliated with The University of Queensland, where he continues to engage in groundbreaking research. His work has garnered attention in the scientific community, contributing to advancements in drug development and therapeutic strategies.
Collaborations
Armishaw has collaborated with esteemed colleagues, including David James Craik and Norelle Lee Daly. These partnerships have enhanced the scope and impact of his research, fostering innovation in the field.
Conclusion
Christopher John Armishaw is a distinguished inventor whose work on cyclised conotoxin peptides has the potential to revolutionize pharmaceutical applications. His contributions to science and collaboration with other experts highlight his commitment to advancing medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile